TRIM67 and non-small cell lung carcinoma: In conclusion, our study demonstrated that TRIM67 plays a significant role in NSCLC via the Notch pathway, suggesting that TRIM67 might be a candidate prognostic biomarker and possible therapeutic target for NSCLC.